Allspring Global Investments
INDV icon

Allspring Global Investments’s Indivior Pharmaceuticals INDV Stock Holding History

Allspring Global Investments’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53M Buy
112,438
+79,622
+243% +$2.89M 0.01% 906
2026
Q1 		$1.01M Buy
32,816
+20,284
+162% +$670K ﹤0.01% 1177
2025
Q4 		$448K Buy
+12,532
New +$383K ﹤0.01% 1405

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allspring Global Investments's INDV Position: Q2 2026 in Review

Allspring Global Investments increased its Indivior Pharmaceuticals (INDV) stake by 243% in Q2 2026, buying an estimated $2.89M and bringing the position to 112,438 shares worth $4.53M. The position accounts for 0.01% of the portfolio, ranked #906.

Allspring Global Investments first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Allspring Global Investments held 112,438 shares of Indivior Pharmaceuticals worth $4.53M as of Q2 2026.
  • Allspring Global Investments bought 79,622 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.89M.
  • Indivior Pharmaceuticals made up 0.01% of Allspring Global Investments's portfolio in Q2 2026, its #906 holding.
  • Allspring Global Investments first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.